Sitemap

American Heart Association retracts a scientific study on the use of e-cigarettes

CorD Recommends

Mlekoprodukt Supports European Week Of Environmentally Sustainable Transport

Environmentally sustainable transport (EST) represents one of...

Alumil Celebrates 20 Years of Manufacturing in Serbia

Established in Greece in 1988 and building...

Miodrag Kostić Becomes Largest Shareholder of Addiko Bank AG

Miodrag Kostić, the head of MK Group,...

Hisense Pours £45 Million into New Factory in Valjevo

Chinese corporation Hisense has announced an investment...

Tourist Taxes in Amsterdam to Become the Highest in Europe

City leaders in Amsterdam have announced a significant increase in tourist taxes, positioning them as the highest in Europe....

Swiss-Serbian Chamber of Commerce-Holycode Working Lunch

Swiss-Serbian Chamber of Commerce SSCC held a working lunch entitled ’’The update of the Swiss start-up ecosystem’’ co-organised with...

Flutter Acquires Majority Stake of MaxBet for €141 Million

The world's largest online betting company, Flutter, has secured a majority ownership in MaxBet, a leading entity in the...

Record Employment Numbers in Montenegro

Montenegro has recorded its highest-ever employment rate, with the number of employed individuals reaching 258,000 in July, announced Prime...

Google Marks its 25th Anniversary

The world’s foremost internet search engine, Google, celebrated its 25th birthday in grand style, presenting a special logo to...

The American Heart Association (AHA) retracted a scientific study where the use of e-cigarettes is directly linked to a risk of heart attack, because the study conclusion is unreliable, as reported in the Association’s journal.

Editors of the specialised journal published a note with the retraction of the study, whose author is Dr. Stanton Glantz, professor of medicine and director of the Center for Tobacco Control Research and Education at University of California San Francisco, with associates, underlining that it is potentially based on misleading results of the study and that key information from the U.S. Population Assessment of Tobacco and Health study.

“There is growing evidence that legally sold and scientifically verified products that do not combust, like e-cigarettes and heated tobacco products, while not risk-free, are a much better alternative to cigarettes for those who would otherwise continue smoking,” as stated in the explanation.

It is added that this evidence is supported by a growing number of independent studies and conclusions of leading expert organizations like the U.S. Food and Drugs Authority, Public Health England and the Royal College of Physicians in Australia.

In recent years, a growing number of governments have been updating older legislation to differentiate the smoke-free category from cigarettes, recognizing their different nature and potential for public health versus smoking. This is the case with the U.S., the U.K., Italy and Portugal, while others, like New Zealand and Greece, have announced steps in this direction.

Another study, by Dr. Auer et al., generated significant coverage that misled the public on the potential risk reduction of a heated tobacco product, IQOS.

This story in the Daily Mail, for instance, reported that “IQOS generates more toxins than originally thought. Philip Morris International, the maker of IQOS, criticized the methodology and conclusions of the study.

The U.S. Food and Drugs Authority in its conclusions on the review of evidence on the product decided not to consider the study because “the data published is not considered adequate for comparing the levels of HPHCs between the IQOS products and combusted cigarettes.”

“There are significant analytical issues in the Auer et al. study, such as lack of testing reference samples, low number of replicates and lack of selectivity on some analytical methods. In comparison, we have not identified specific issues with the applicant’s methods,” concluded Philip Morris International.

The decision of one of the leading scientific publications to retract the study which links the use of e-cigarettes with the myocardial infarctions is also supported by the National Institutes of Health, stating that this act “can help avoid potential harm to a scientific field, wasted resources, lost time and, in some cases, harm to patient populations, if done in a timely manner”.

“This story simply confirms what I have been arguing for a long time – that there is a profound anti-e-cigarette bias among tobacco-control researchers, and this is precisely what caused this fiasco,” said Michael Siegel, a professor of community health sciences at Boston University.

One of the first who called for the retraction of the study, published in June last year, was New York University professor David Abrams, a former head of the National Institute for Health’s Office on behavioural and social science research, with a group of 16 academics, scientists and other public health experts. Abrams is now drafting letters to the National Institutes of Health’s Office of Research Integrity and the University of California San Francisco’s president to request investigations of other Glantz research.

Related Articles

NALED’s Annual September Meeting Celebrates Innovation and Reform

The renowned September Meeting, now in its 17th year, was recently hosted by NALED under the theme "Innovations - New Reforms and Ideas for...

Philip Morris Announces $100 Million Investment in Niš Facility

Philip Morris International is set to invest $100 million in a new facility in Niš, Serbia, creating approximately 200 new jobs, according to announcements...

Massimo Andolina, President Europe Region At Philip Morris International (PMI)

Aiming To Replace Cigarettes

Philip Morris is the current leader and trailblazer in reducing the harm caused by tobacco. It is one of the most inspiring cases of...

Philip Morris Awarded “Top Employer” Certificate For the Seventh Year in a Row

For the seventh time in a row, Philip Morris Serbia has been awarded the “Top Employer Serbia 2022” Award from the Netherlands-based international independent...

Philip Morris Begins Commercialization Of lil SOLID 2.0 Device Supported By IQOS

Collaboration with KT&G company, the manufacturer of this device, broadens the Company’s portfolio of smoke-free products for those adults who would otherwise continue to...

Nicotine Products Efficient In The Battle Against Smoking

Electronic devices containing nicotine are the most efficient tool for quitting smoking in England, according to the latest report of Public Health England. Data shows...

Tommaso Di Giovanni, Vice President Philip Morris International

Can There Be An End To Cigarettes?

Philip Morris International plays an important part and has ramped up its efforts to communicate the benefits and risks to people who smoke despite...

André Calantzopoulos, New Chairman Of Philip Morris International Board

Philip Morris International’s current Chief Executive Officer André Calantzopoulos was appointed new Executive Chairman of the Board, after Louis Camilleri had retired for personal...